AU2001251223A1 - Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer - Google Patents

Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer

Info

Publication number
AU2001251223A1
AU2001251223A1 AU2001251223A AU5122301A AU2001251223A1 AU 2001251223 A1 AU2001251223 A1 AU 2001251223A1 AU 2001251223 A AU2001251223 A AU 2001251223A AU 5122301 A AU5122301 A AU 5122301A AU 2001251223 A1 AU2001251223 A1 AU 2001251223A1
Authority
AU
Australia
Prior art keywords
staging
diagnosing
imaging
compositions
monitoring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001251223A
Inventor
Sei-Yu Chen
Ping Hu
Roberto A. Macina
Jason Pluta
Herve Recipon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diadexus Inc
Original Assignee
Diadexus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diadexus Inc filed Critical Diadexus Inc
Publication of AU2001251223A1 publication Critical patent/AU2001251223A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001251223A 2000-03-30 2001-03-30 Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer Abandoned AU2001251223A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19309500P 2000-03-30 2000-03-30
US60/193,095 2000-03-30
PCT/US2001/010591 WO2001075169A2 (en) 2000-03-30 2001-03-30 Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer

Publications (1)

Publication Number Publication Date
AU2001251223A1 true AU2001251223A1 (en) 2001-10-15

Family

ID=22712268

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001251223A Abandoned AU2001251223A1 (en) 2000-03-30 2001-03-30 Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer

Country Status (3)

Country Link
US (1) US20020068307A1 (en)
AU (1) AU2001251223A1 (en)
WO (1) WO2001075169A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006508644A (en) * 2002-08-14 2006-03-16 エルジー・ライフ・サイエンシーズ・リミテッド Gastric cancer-related gene family
EP2290071B1 (en) * 2004-05-28 2014-12-31 Asuragen, Inc. Methods and compositions involving microRNA
EP2281888B1 (en) 2004-11-12 2015-01-07 Asuragen, Inc. Methods and compositions involving miRNA and miRNA inhibitor molecules
AU2007299828C1 (en) * 2006-09-19 2014-07-17 Interpace Diagnostics, Llc MicroRNAs differentially expressed in pancreatic diseases and uses thereof
WO2008073915A2 (en) * 2006-12-08 2008-06-19 Asuragen, Inc. Micrornas differentially expressed in leukemia and uses thereof
US20090175827A1 (en) * 2006-12-29 2009-07-09 Byrom Mike W miR-16 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
KR100863440B1 (en) 2007-02-07 2008-10-16 주식회사 마크로젠 Kit and method for detrmining metastasis or dissemination of gastric cancer
US20090131354A1 (en) * 2007-05-22 2009-05-21 Bader Andreas G miR-126 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
US20090232893A1 (en) * 2007-05-22 2009-09-17 Bader Andreas G miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
CN101801419A (en) * 2007-06-08 2010-08-11 米尔纳疗法公司 Gene and path as the miR-34 regulation and control for the treatment of the target of intervening
WO2009036332A1 (en) 2007-09-14 2009-03-19 Asuragen, Inc. Micrornas differentially expressed in cervical cancer and uses thereof
US20090186015A1 (en) * 2007-10-18 2009-07-23 Latham Gary J Micrornas differentially expressed in lung diseases and uses thereof
US8071562B2 (en) 2007-12-01 2011-12-06 Mirna Therapeutics, Inc. MiR-124 regulated genes and pathways as targets for therapeutic intervention
WO2009111643A2 (en) * 2008-03-06 2009-09-11 Asuragen, Inc. Microrna markers for recurrence of colorectal cancer
US8258111B2 (en) 2008-05-08 2012-09-04 The Johns Hopkins University Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
US9644241B2 (en) 2011-09-13 2017-05-09 Interpace Diagnostics, Llc Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0507868A4 (en) * 1989-12-27 1992-11-04 Us Commerce Diagnostic probe for detecting human stomach cancer
FI971124A0 (en) * 1997-03-18 1997-03-18 Locus Genex Oy Method Foer diagnosis av magcancer

Also Published As

Publication number Publication date
WO2001075169A3 (en) 2003-01-23
WO2001075169A2 (en) 2001-10-11
US20020068307A1 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
AU2001251013A1 (en) Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer
AU2002339865A1 (en) Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors
AU2001250932A1 (en) Compositions and methods of diagnosing, monitoring, staging, imaging and treating prostate cancer
EP1408820A4 (en) Capsule and method for treating or diagnosing the intestinal tract
AU2001251223A1 (en) Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer
EP1239874A4 (en) Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
AU2001227966A1 (en) Methods for treating tumors
AU2002351405A1 (en) Method and apparatus for noise tomography
AU2002243549A1 (en) Diagnostic and monitoring methods for cancer
AU2002360766A1 (en) Methods for cancer imaging
AU2003300368A8 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
AU1465801A (en) Methods for cancer prognosis and diagnosis
MXPA03002323A (en) Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators.
AU1233701A (en) Methods and compositions for treating atheroma, tumors and other neoplastic tissue
AU2001289123A1 (en) Compounds and methods for diagnosing and treating amyloid-related conditions
GB0004232D0 (en) Diagnostic method
AU4787899A (en) Methods, apparatuses and imaging mode for tomographic imaging
AU2001246853A1 (en) X-ray inspection system
AU2001249431A1 (en) Compositions and methods of diganosing, monitoring, staging, imaging and treating mammary gland cancer
AU2001268633A1 (en) Method of diagnosing, monitoring, staging, imaging and treating breast cancer
AU2001241656A1 (en) Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
AU1333401A (en) Methods for analyzing the insertion capabilities of modified group ii introns
PT1453995E (en) Method for making propylene monofilaments, propylene monofilaments and their use
AU2001271621A1 (en) Method of diagnosing, monitoring, staging, imaging and treating colon cancer
AU1554401A (en) X-ray tester